Tag: Genetically Engineered Cell Therapy
-
“Is Curing Patients a Sustainable Business Model?” Goldman Sachs Asks Shareholders
Big bank admits it might not be worthwhile to invest in treatments that actually cure disease
Big bank admits it might not be worthwhile to invest in treatments that actually cure disease